Abstract: A fish handling unit for processing live fish is provided. Such fish handling unit includes an inspection system configured to inspect a plurality of live fish. A conveyor assembly transports the live fish to the inspection system. At least one robotic cell is in communication with the inspection system. The robotic cell has a controller configured to control operation thereof. An end effector is operably engaged with the robotic cell. The end effector interacts with the live fish moving along the conveyor assembly, based on information determined by the inspection system and received by the controller. The end effector may optionally be an integrated gripper and injection assembly capable of orientation and injection of the live fish. Associated devices and methods are also provided.
Type:
Grant
Filed:
August 6, 2018
Date of Patent:
February 11, 2025
Assignee:
Pharmaq AS
Inventors:
Jorn Stale Pettersen, Remy Kristian Oddoy, Johan Odd Moflag, Steffen Langseth
Abstract: The present invention describes vaccine compositions for treatment and/or prevention against sea lice infestation in salmon. The present invention further describes nucleic acids, host cells, vectors and methods of using said vaccine for the prevention and/or treatment of sea lice infestation in salmon.
Type:
Grant
Filed:
October 1, 2021
Date of Patent:
July 30, 2024
Assignee:
Pharmaq AS
Inventors:
Jose de Jesus de la Fuente Garcia, Marinela Contreras Rojo, Margarita Maria Villar Rayo, Marius Andre De Feijter Karlsen, Bjorn Erik Brudeseth, Karine Lindmo Yttredal, Christer Ross Wiik-Nielsen, Rolf Hetlelid Olsen, Liv Blom Hungerholdt
Abstract: The present invention describes vaccine compositions for treatment and/or prevention against sea lice infestation in salmon. The present invention further describes nucleic acids, host cells, vectors and methods of using said vaccine for the prevention and/or treatment of sea lice infestation in salmon.
Type:
Grant
Filed:
August 16, 2017
Date of Patent:
November 9, 2021
Assignee:
Pharmaq AS
Inventors:
Jose de Jesus de la Fuente Garcia, Marinela Contreras Rojo, Margarita Maria Villar Rayo, Marius Andre De Feijter Karlsen, Bjorn Erik Brudeseth, Karine Lindmo Yttredal, Christer Ross Wiik-Nielsen, Rolf Hetlelid Olsen, Liv Blom Hungerholdt
Abstract: The present invention relates to an attenuated Piscirickettsia salmonis bacterium. The bacterium comprises mutations in the amino acid sequence of each of the rpoD, FecR, ATP-grasp domain protein, and FtsH gene products. The invention also relates to vaccines comprising the attenuated Piscirickettsia salmonis bacterium that are useful for the prevention of microbial pathogenesis. In addition, the invention relates to methods for the preparation of attenuated Piscirickettsia salmonis bacteria, and vaccines comprising such bacteria.
© 2025 Justia
